Janet V. Cross
- Phone: 434-243-9401
Primary Appointment
Associate Professor, Pathology
Education
- BS, Recombinant Gene Technology, Medical Technology, State University of New York College at Fredonia
- PhD, Molecular Biology and Microbiology, Case Western Reserve University
Research Disciplines
Cancer Biology, Experimental Pathology, Immunology, Molecular Biology
Research Interests
Contribution of the Inflammatory Microenvironment to Tumor Initiation, Progression and Metastasis; Molecular Mechanisms of Cancer Chemoprevention
Research Description
Personal Statement
Training
- Biodefense & Infectious Diseases Short-Term Training to Increase Diversity in Biomedical Sciences
Selected Publications
2019
Gigliotti, J. C., Tin, A., Pourafshar, S., Cechova, S., Wang, Y. T., Sung, S. -S. J., . . . Le, T. H. (2020). GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 31(1), 102-116. doi:10.1681/ASN.2019050449
Calderon-Garciduenas, L., Gonzalez-Maciel, A., Mukherjee, P. S., Reynoso-Robles, R., Perez-Guille, B., Gayosso-Chavez, C., . . . Maher, B. A. (2019). Combustion- and friction-derived magnetic air pollution nanoparticles in human hearts. ENVIRONMENTAL RESEARCH, 176. doi:10.1016/j.envres.2019.108567
2018
Balogh, K. N., Templeton, D. J., & Cross, J. V. (2018). Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses. PLOS ONE, 13(6). doi:10.1371/journal.pone.0197702
2017
Dill, E. A., Gru, A. A., Atkins, K. A., Friedman, L. A., Moore, M. E., Bullock, T. N., . . . Mills, A. M. (2017). PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages An Assessment of 245 Primary and 40 Metastatic Tumors. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41(3), 334-342. doi:10.1097/PAS.0000000000000780
Gottlieb, C. E., Mills, A. M., Cross, J. V., & Ring, K. L. (2017). Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors. GYNECOLOGIC ONCOLOGY, 144(3), 607-612. doi:10.1016/j.ygyno.2016.12.021
Balogh, K. N., & Cross, J. V. (2017). A role for Macrophage Migration Inhibitory Factor (MIF) in breast cancer growth and metastasis. CANCER IMMUNOLOGY RESEARCH, 5(3). doi:10.1158/2326-6074.TUMIMM16-A03
Dill, E., Thompson, E., Gottlieb, C., Bullock, T., Cross, J., Atkins, K., . . . Mills, A. (2017). PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes: An Assessment of 245 Primary and 40 Metastatic Tumors. In MODERN PATHOLOGY Vol. 30 (pp. 39A). Retrieved from https://www.webofscience.com/
Dill, E., Thompson, E., Gottlieb, C., Bullock, T., Cross, J., Atkins, K., . . . Mills, A. (2017). PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes: An Assessment of 245 Primary and 40 Metastatic Tumors. In LABORATORY INVESTIGATION Vol. 97 (pp. 39A). Retrieved from https://www.webofscience.com/
2016
Damle, S. R., Martin, R. K., Cross, J. V., & Conrad, D. H. (2017). Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. MUCOSAL IMMUNOLOGY, 10(1), 205-214. doi:10.1038/mi.2016.29
Balogh, K. N., & Cross, J. V. (2016). The macrophage migration inhibitory factor promotes breast cancer metastasis through interaction with the host immune response. In CANCER IMMUNOLOGY RESEARCH Vol. 4. doi:10.1158/2326-6074.CRICIMTEATIAACR15-A152